Clinical Trial Update: Rituximab to Treat Stiff Person Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating rituximab for Stiff Person Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stiff-person Syndrome

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Stiff Person Syndrome | Phase 2 | Status: COMPLETED